Bioavailability and tissular distribution of docetaxel, a P-glycoprotein substrate, are modified by interferon-alpha in rats. (Q48256604)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17331344%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

title

Bioavailability and tissular distribution of docetaxel, a P-glycoprotein substrate, are modified by interferon-alpha in rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17331344%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

1 reference

Laurence Bonhomme-Faivre

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17331344%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Makrem Ben Reguiga

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17331344%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Robert Farinotti

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17331344%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

1 March 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17331344%20AND%20SRC:MED&resulttype=core&format=json

Journal of Pharmacy and Pharmacology

26 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17331344%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

59

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17331344%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17331344%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

401-408

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17331344%20AND%20SRC:MED&resulttype=core&format=json

Down-regulation of human topoisomerase IIalpha correlates with altered expression of transcriptional regulators NF-YA and Sp1.

26 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.3.0010

Modification of the P-glycoprotein dependent pharmacokinetics of digoxin in rats by human recombinant interferon-alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.3.0010

NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.3.0010

Recombinant interleukin-2 treatment decreases P-glycoprotein activity and paclitaxel metabolism in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.3.0010

Effect of recombinant interleukin-2 pretreatment on oral and intravenous digoxin pharmacokinetics and P-glycoprotein activity in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.3.0010

A good practice guide to the administration of substances and removal of blood, including routes and volumes

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.3.0010

Permeability modulation of human intestinal Caco-2 cell monolayers by interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.3.0010

Improved penetration of docetaxel into the brain by co-administration of inhibitors of P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.3.0010

Drugs as P-glycoprotein substrates, inhibitors, and inducers

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.3.0010

Acetylation of Stat1 modulates NF-kappaB activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.3.0010

Oral bioavailability of docetaxel in combination with OC144-093 (ONT-093).

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.3.0010

Interspecies scaling of interferon disposition and comparison of allometric scaling with concentration-time transformations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.3.0010

Role of P-glycoprotein in pharmacokinetics: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.3.0010

Coadministration of cyclosporine strongly enhances the oral bioavailability of docetaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.3.0010

Docetaxel for treatment of solid tumours: a systematic review of clinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.3.0010

Increased activity of CYP3A enzyme in primary cultures of rat hepatocytes treated with docetaxel: comparative evaluation with paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.3.0010

Review: tubulin function, action of antitubulin drugs, and new drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.3.0010

Interferon-alpha: regulatory effects on cell cycle and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.3.0010

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.3.0010

Paclitaxel metabolism in rat and human liver microsomes is inhibited by phenolic antioxidants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.3.0010

Polarized transport of docetaxel and vinblastine mediated by P-glycoprotein in human intestinal epithelial cell monolayers

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.3.0010

Cytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.3.0010

Transcriptional repression of protein kinase Calpha via Sp1 by wild type p53 is involved in inhibition of multidrug resistance 1 P-glycoprotein phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.3.0010

21 January 2018

Identifiers

DOI

10.1211/JPP.59.3.0010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17331344%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference